Altrafin AG Has $228,000 Stock Holdings in Taiwan Semiconductor Manufacturing Company Ltd. $TSM - MarketBeat

In August 2026, Altrafin AG significantly reduced its stake in Taiwan Semiconductor Manufacturing Company (TSMC), cutting its holdings by 99%, retaining only 478 shares valued at approximately $228,00... Read original →

Altrafin AG’s significant reduction in TSMC holdings signals institutional skepticism toward current semiconductor valuations. Despite TSMC’s strong quarterly performance, its dominant position in AI chips and advanced processes is drawing increased scrutiny amid U.S.-China tech decoupling. This move may trigger broader investor reassessment of TSMC’s exposure in China Taiwan/ Taiwan, China. Meanwhile, the TSMC-Sony $4.7B CMOS plant underscores global expansion ambitions, yet could intensify capital reallocation pressures. SoftBank’s selling spree may spark further market volatility, while local supply chains face mounting pressure for technological self-reliance. Over the next 12-24 months, if TSMC fails to sustain profit growth, valuation corrections may emerge, though its AI chip leadership remains a key strategic asset.